Huang JianPing, Sha Li, Zhang Hao, Tang XueFeng, Zhang XiWei
Department of General Surgery, Shanghai Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Int Surg. 2015 May;100(5):809-13. doi: 10.9738/INTSURG-D-14-00134.1.
Desmoplastic small round cell tumor (DSRCT) is an extremely rare, highly aggressive, malignant tumor of undetermined histogenesis. Adolescent males are primarily affected with a typically abdominal or pelvic mass. Diagnosis is based on histologic analysis of biopsy and cytogenetic studies. Owing to the rarity of the tumor and the unusually aggressive presentation, treatment is challenging and has not been standardized. DSRCT has a very poor prognosis, with a median survival range of 17 to 25 months. In this work, we report a case of DSRCT in the transverse colon, which has never before been reported in the literature. Our case study is of a 30-year-old Chinese female who presented with a history of 6 months abdominal discomfort and fatigue. A palpable, hardly mobile mass was detected in the right lower quadrant abdomen by physical examination. Abdominal and pelvic magnetic resonance imaging revealed an 8.0 × 10.5 × 11.1-cm mass with no pulmonary and hepatic metastasis. The patient underwent exploratory laparotomy and transverse colectomy, which revealed a mass in the transverse colon and no metastasis in the peritoneum, greater omentum, or mesentery. Immunohistochemistry findings revealed positive staining for epithelial, mesenchymal, and neural markers, which confirmed the presentation of DSRCT. A 6-month postoperative follow-up failed to find any recurrence. DSRCT is a highly aggressive, malignant, mesenchymal tumor with a very poor prognosis. No consensus has been reached for the treatment protocol of DSRCT. However, debulking surgery with postoperative chemotherapy or radiotherapy might promise more optimistic results on survival.
促结缔组织增生性小圆细胞肿瘤(DSRCT)是一种极为罕见、侵袭性极强、组织发生不明的恶性肿瘤。主要影响青春期男性,通常表现为腹部或盆腔肿块。诊断基于活检的组织学分析和细胞遗传学研究。由于该肿瘤罕见且表现异常侵袭性,治疗具有挑战性且尚未标准化。DSRCT预后极差,中位生存期为17至25个月。在本研究中,我们报告了一例横结肠DSRCT病例,此前文献中从未有过报道。我们的病例研究对象是一名30岁的中国女性,有6个月的腹部不适和疲劳病史。体格检查在右下腹部触及一个可触及、活动度差的肿块。腹部和盆腔磁共振成像显示一个8.0×10.5×11.1厘米的肿块,无肺和肝转移。患者接受了剖腹探查术和横结肠切除术,术中发现横结肠有肿块,腹膜、大网膜或肠系膜无转移。免疫组化结果显示上皮、间充质和神经标志物呈阳性染色,证实为DSRCT表现。术后6个月随访未发现任何复发。DSRCT是一种侵袭性极强的恶性间充质肿瘤,预后极差。对于DSRCT的治疗方案尚未达成共识。然而,减瘤手术联合术后化疗或放疗可能会带来更乐观的生存结果。